Depression and Anxiety Trial, Recruiting NCT05665491 Sponsor: Mclean Hospital Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT05665491
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For parent participants:

  • People who can speak and understand English well enough to complete the study assessments
  • People who have at least a mild level of anxiety, based on a standard anxiety questionnaire score
  • People who show at least a minimal tendency to interpret unclear situations negatively, based on a specific thinking-style test
  • People who do not have current mental health symptoms that would affect their ability to agree to take part or complete the study tasks
  • People who, if currently receiving treatment, have been on the same medication or therapy for at least 8 weeks
  • People who do not have severe thoughts of self-harm, based on a questionnaire score
  • People who own an iOS or Android smartphone
  • People who have shared or full custody of their child

For child participants:

  • Children aged 7 to 12 years old
  • Children who can speak and understand English well enough to complete the study assessments
  • Children who have not been diagnosed with an intellectual disability or autism spectrum disorder, based on parent or doctor report
  • Children who do not have current mental health symptoms that would prevent them from understanding and agreeing to take part in the research
  • Children whose general thinking and reasoning ability scores 80 or above on a standard intelligence assessment, to ensure they can understand the study procedures
  • Children who, if currently receiving treatment, have been on the same medication or therapy for at least 8 weeks
  • Children who do not have severe thoughts of self-harm, based on a questionnaire score

Who may not be able to join:

For parent participants:

  • People who cannot speak or understand English sufficiently to complete the assessments
  • People whose anxiety falls below the minimal threshold on the standard questionnaire
  • People whose thinking-style test results do not show at least a minimal tendency toward negative interpretation
  • People experiencing current mental health symptoms that would interfere with consent or completing study tasks
  • People currently on medications or therapy that have not been stable for at least 8 weeks
  • People with severe thoughts of self-harm based on questionnaire results
  • People who do not own an iOS or Android smartphone
  • People who do not have shared or full custody of their child

For child participants:

  • Children outside the 7 to 12 age range
  • Children who cannot speak or understand English sufficiently to complete the assessments
  • Children who have a diagnosis of intellectual disability or autism spectrum disorder
  • Children experiencing current mental health symptoms that would prevent understanding or agreement to participate
  • Children who score below 80 on the standard thinking and reasoning ability assessment
  • Children currently on medications or therapy that have not been stable for at least 8 weeks
  • Children with severe thoughts of self-harm based on questionnaire results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Courtney Beard, PhD, Mclean Hospital

Phone: 617-855-3557

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Mclean Hospital
Registry
ClinicalTrials.gov
Start date
28 July 2023
Est. completion
30 November 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Parent behavior

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov